接种ChAdOx1 nCoV-19（牛津-阿斯利康）疫苗后发生的自身免疫性肝炎。 - Suppr

Suppr

超能文献

Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine.

作者信息

Clayton-Chubb Daniel, Schneider Daniel, Freeman Elliot, Kemp William, Roberts Stuart K

机构信息

Department of Gastroenterology, Alfred Health, Melbourne, Victoria, Australia.

出版信息

J Hepatol. 2021 Nov;75(5):1249-1250. doi: 10.1016/j.jhep.2021.06.014. Epub 2021 Jun 22.

DOI:10.1016/j.jhep.2021.06.014

PMID:34171435

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8219312/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7b9/8219312/6b2da56e41c7/gr1_lrg.jpg

相似文献

Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine.

J Hepatol. 2021 Nov;75(5):1249-1250. doi: 10.1016/j.jhep.2021.06.014. Epub 2021 Jun 22.

A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine.

Neurol Sci. 2021 Nov;42(11):4747-4749. doi: 10.1007/s10072-021-05467-w. Epub 2021 Jul 17.

Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation.

Semin Thromb Hemost. 2022 Feb;48(1):109-111. doi: 10.1055/s-0041-1728831. Epub 2021 May 10.

Onset/flare of psoriasis following the ChAdOx1 nCoV-19 Corona virus vaccine (Oxford-AstraZeneca/Covishield): Report of two cases.

Dermatol Ther. 2021 Sep;34(5):e15085. doi: 10.1111/dth.15085. Epub 2021 Aug 10.

Exuberant lichenoid eruption after Oxford-AstraZeneca COVID-19 vaccine: a singular case.

J Eur Acad Dermatol Venereol. 2022 Apr;36(4):e268-e270. doi: 10.1111/jdv.17872. Epub 2021 Dec 22.

Inverse lichen planus post Oxford-AstraZeneca COVID-19 vaccine.

J Cosmet Dermatol. 2022 Mar;21(3):883-885. doi: 10.1111/jocd.14738. Epub 2022 Jan 8.

Acute onset ocular myasthenia gravis after vaccination with the Oxford-AstraZeneca COVID-19 vaccine.

Orbit. 2023 Dec;42(6):630-634. doi: 10.1080/01676830.2022.2062777. Epub 2022 May 2.

Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an 'AstraZeneca arm'?

J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e711-e714. doi: 10.1111/jdv.17476. Epub 2021 Jul 12.

Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster.

Lancet. 2021 Mar 6;397(10277):854-855. doi: 10.1016/S0140-6736(21)00528-6.

Bullous Sweet syndrome following SARS-CoV-2 Oxford AstraZeneca vaccine.

Br J Dermatol. 2022 Mar;186(3):e110. doi: 10.1111/bjd.20876. Epub 2021 Nov 24.

引用本文的文献

The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug-Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI Initiative.

Drug Saf. 2025 Aug 5. doi: 10.1007/s40264-025-01591-0.

Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics.

Signal Transduct Target Ther. 2025 Mar 17;10(1):102. doi: 10.1038/s41392-025-02168-0.

Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations.

Front Immunol. 2025 Jan 31;16:1510770. doi: 10.3389/fimmu.2025.1510770. eCollection 2025.

Case report of secondary T-cell deficiency following the AstraZeneca COVID-19 vaccine.

J Allergy Clin Immunol Glob. 2024 Sep 6;3(4):100339. doi: 10.1016/j.jacig.2024.100339. eCollection 2024 Nov.

The Epidemiology of Newly Recognized Causes of Drug-Induced Liver Injury: An Update.

Pharmaceuticals (Basel). 2024 Apr 18;17(4):520. doi: 10.3390/ph17040520.

Immunogenicity and adverse events of the COVID-19 vaccines in healthy and individuals with autoimmune diseases in an Iranian population.

Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241239202. doi: 10.1177/03946320241239202.

Acute hepatitis following mRNA BNT162b2 COVID-19 vaccination.

Can Liver J. 2022 Nov 7;5(4):535-539. doi: 10.3138/canlivj-2022-0014. eCollection 2022 Nov.

Investigating Acute Hepatitis after SARS-CoV-2 Vaccination or Infection: A Genetic Case Series.

Biomedicines. 2023 Oct 20;11(10):2848. doi: 10.3390/biomedicines11102848.

SARS-CoV-2 vaccine-triggered autoimmunity: Molecular mimicry and/or bystander activation of the immune system.

Bioimpacts. 2023;13(4):269-273. doi: 10.34172/bi.2023.27494. Epub 2023 Jun 27.

Clinical Features of COVID-19 Vaccine-Associated Autoimmune Hepatitis: A Systematic Review.

Diseases. 2023 May 30;11(2):80. doi: 10.3390/diseases11020080.

本文引用的文献

Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?

J Hepatol. 2021 Jul;75(1):222-224. doi: 10.1016/j.jhep.2021.04.003. Epub 2021 Apr 20.

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.

N Engl J Med. 2021 Jun 3;384(22):2124-2130. doi: 10.1056/NEJMoa2104882. Epub 2021 Apr 9.

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.

N Engl J Med. 2021 Apr 15;384(15):1412-1423. doi: 10.1056/NEJMoa2101765. Epub 2021 Feb 24.

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

J Hepatol. 1999 Nov;31(5):929-38. doi: 10.1016/s0168-8278(99)80297-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验